EA ELECTRONIC ARTS INC More: the full row for ELECTRONIC ARTS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,035,000 shares; 2026Q1: 7,470,000 shares 7,470,000 $1.52B 9.03% +2,435,000 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,317,692 shares; 2024Q4: 13,248,692 shares; 2025Q1: 13,534,692 shares; 2025Q2: 14,325,692 shares; 2025Q3: 14,625,692 shares; 2025Q4: 14,582,796 shares; 2026Q1: 13,604,796 shares 13,604,796 $1.32B 7.84% -978,000 The filing omitted confidential holdings, a later amendment may add them. Timeline AMZN AMAZON COM INC More: the full row for AMAZON COM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,034,600 shares; 2025Q3: 3,505,700 shares; 2025Q4: 4,499,894 shares; 2026Q1: 4,218,394 shares 4,218,394 $879M 5.21% -281,500 The filing omitted confidential holdings, a later amendment may add them. Timeline MSFT MICROSOFT CORP More: the full row for MICROSOFT CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,466,747 shares; 2024Q4: 1,633,147 shares; 2025Q1: 2,285,835 shares; 2025Q2: 1,747,835 shares; 2025Q3: 1,913,135 shares; 2025Q4: 2,214,079 shares; 2026Q1: 2,344,779 shares 2,344,779 $868M 5.15% +130,700 The filing omitted confidential holdings, a later amendment may add them. Timeline AON AON PLC More: the full row for AON PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,706,000 shares; 2024Q4: 1,832,733 shares; 2025Q1: 1,361,744 shares; 2025Q2: 1,986,417 shares; 2025Q3: 2,278,017 shares; 2025Q4: 2,665,238 shares; 2026Q1: 2,512,638 shares 2,512,638 $811M 4.81% -152,600 The filing omitted confidential holdings, a later amendment may add them. Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,747,000 shares; 2024Q4: 4,195,000 shares; 2025Q1: 5,731,000 shares; 2025Q2: 7,900,000 shares; 2025Q3: 8,192,000 shares; 2025Q4: 8,998,463 shares; 2026Q1: 9,365,463 shares 9,365,463 $695M 4.12% +367,000 The filing omitted confidential holdings, a later amendment may add them. Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,861,006 shares; 2024Q4: 5,930,006 shares; 2025Q1: 6,107,006 shares; 2025Q2: 6,172,006 shares; 2025Q3: 6,196,006 shares; 2025Q4: 6,144,006 shares; 2026Q1: 6,348,906 shares 6,348,906 $669M 3.97% +204,900 The filing omitted confidential holdings, a later amendment may add them. Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,557,309 shares; 2024Q4: 4,431,609 shares; 2025Q1: 4,547,809 shares; 2025Q2: 4,821,809 shares; 2025Q3: 4,253,452 shares; 2025Q4: 3,914,366 shares; 2026Q1: 3,207,366 shares 3,207,366 $641M 3.8% -707,000 The filing omitted confidential holdings, a later amendment may add them. Timeline EXEL EXELIXIS INC More: the full row for EXELIXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 25,410,500 shares; 2024Q4: 23,439,500 shares; 2025Q1: 22,533,500 shares; 2025Q2: 16,035,500 shares; 2025Q3: 19,501,500 shares; 2025Q4: 15,709,500 shares; 2026Q1: 13,111,010 shares 13,111,010 $562M 3.33% -2,598,490 The filing omitted confidential holdings, a later amendment may add them. Timeline AVGO BROADCOM INC More: the full row for BROADCOM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 892,400 shares; 2026Q1: 1,779,500 shares 1,779,500 $551M 3.27% +887,100 The filing omitted confidential holdings, a later amendment may add them. Timeline UNH UNITEDHEALTH GROUP INC More: the full row for UNITEDHEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,097,900 shares; 2024Q4: 1,462,500 shares; 2025Q1: 1,497,900 shares; 2025Q2: 1,617,300 shares; 2025Q3: 1,886,500 shares; 2025Q4: 1,598,906 shares; 2026Q1: 1,821,706 shares 1,821,706 $493M 2.92% +222,800 The filing omitted confidential holdings, a later amendment may add them. Timeline SNPS SYNOPSYS INC More: the full row for SYNOPSYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 999,200 shares; 2026Q1: 1,213,300 shares 1,213,300 $481M 2.85% +214,100 The filing omitted confidential holdings, a later amendment may add them. Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,425,657 shares; 2024Q4: 5,022,957 shares; 2025Q1: 3,762,757 shares; 2025Q2: 3,981,057 shares; 2025Q3: 4,746,557 shares; 2025Q4: 7,439,564 shares; 2026Q1: 7,470,684 shares 7,470,684 $469M 2.78% +31,120 The filing omitted confidential holdings, a later amendment may add them. Timeline TMO THERMO FISHER SCIENTIFIC INC More: the full row for THERMO FISHER SCIENTIFIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 709,456 shares; 2024Q4: 1,233,256 shares; 2025Q1: 1,035,856 shares; 2025Q2: 1,383,241 shares; 2025Q3: 1,258,241 shares; 2025Q4: 635,685 shares; 2026Q1: 881,485 shares 881,485 $433M 2.57% +245,800 The filing omitted confidential holdings, a later amendment may add them. Timeline KKR KKR & CO INC More: the full row for KKR & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,017,700 shares; 2026Q1: 4,671,800 shares 4,671,800 $432M 2.56% +2,654,100 The filing omitted confidential holdings, a later amendment may add them. Timeline LNTH LANTHEUS HLDGS INC More: the full row for LANTHEUS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,955,227 shares; 2024Q4: 5,316,227 shares; 2025Q1: 6,023,227 shares; 2025Q2: 6,722,227 shares; 2025Q3: 3,477,227 shares; 2025Q4: 5,427,479 shares; 2026Q1: 5,583,479 shares 5,583,479 $424M 2.51% +156,000 The filing omitted confidential holdings, a later amendment may add them. Timeline WAB WABTEC More: the full row for WABTEC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,211,398 shares; 2024Q4: 1,430,198 shares; 2025Q1: 1,608,098 shares; 2025Q2: 1,308,198 shares; 2025Q3: 2,205,098 shares; 2025Q4: 2,476,003 shares; 2026Q1: 1,609,403 shares 1,609,403 $402M 2.38% -866,600 The filing omitted confidential holdings, a later amendment may add them. Timeline SCHW CHARLES SCHWAB CORP (THE) More: the full row for CHARLES SCHWAB CORP (THE) Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,169,000 shares; 2025Q1: 3,832,857 shares; 2025Q2: 3,959,057 shares; 2025Q3: 3,251,657 shares; 2025Q4: 3,339,657 shares; 2026Q1: 3,955,657 shares 3,955,657 $372M 2.2% +616,000 The filing omitted confidential holdings, a later amendment may add them. Timeline LQDA LIQUIDIA CORPORATION More: the full row for LIQUIDIA CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,290,956 shares; 2024Q4: 3,290,956 shares; 2025Q1: 3,990,956 shares; 2025Q2: 4,238,762 shares; 2025Q3: 8,565,638 shares; 2025Q4: 8,656,038 shares; 2026Q1: 8,656,038 shares 8,656,038 $327M 1.94% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CRNX CRINETICS PHARMACEUTICALS IN More: the full row for CRINETICS PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,162,000 shares; 2024Q4: 4,075,098 shares; 2025Q1: 4,605,098 shares; 2025Q2: 4,646,098 shares; 2025Q3: 5,770,098 shares; 2025Q4: 6,933,098 shares; 2026Q1: 8,338,098 shares 8,338,098 $303M 1.8% +1,405,000 The filing omitted confidential holdings, a later amendment may add them. Timeline GOOG ALPHABET INC More: the full row for ALPHABET INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,410,540 shares; 2024Q4: 2,080,540 shares; 2025Q1: 1,666,040 shares; 2025Q2: 1,761,840 shares; 2025Q3: 1,120,940 shares; 2025Q4: 787,040 shares; 2026Q1: 996,231 shares 996,231 $286M 1.69% +209,191 The filing omitted confidential holdings, a later amendment may add them. Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 37,000 shares; 2024Q4: 37,000 shares; 2025Q1: 37,000 shares; 2025Q2: 37,000 shares; 2025Q3: 37,000 shares; 2025Q4: 37,000 shares; 2026Q1: 9,675,000 shares 9,675,000 $268M 1.59% +9,638,000 The filing omitted confidential holdings, a later amendment may add them. Timeline V VISA INC More: the full row for VISA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 752,010 shares; 2024Q4: 549,510 shares; 2025Q1: 474,210 shares; 2025Q2: 308,810 shares; 2025Q3: 599,810 shares; 2025Q4: 695,910 shares; 2026Q1: 840,710 shares 840,710 $254M 1.51% +144,800 The filing omitted confidential holdings, a later amendment may add them. Timeline ARMK ARAMARK More: the full row for ARAMARK Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,636,937 shares; 2024Q4: 11,410,340 shares; 2025Q1: 16,241,996 shares; 2025Q2: 12,899,701 shares; 2025Q3: 8,996,202 shares; 2025Q4: 9,357,046 shares; 2026Q1: 6,135,431 shares 6,135,431 $249M 1.47% -3,221,615 The filing omitted confidential holdings, a later amendment may add them. Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,208,123 shares; 2024Q4: 8,239,123 shares; 2025Q1: 9,928,111 shares; 2025Q2: 10,013,111 shares; 2025Q3: 10,063,111 shares; 2025Q4: 10,063,111 shares; 2026Q1: 10,134,696 shares 10,134,696 $242M 1.43% +71,585 The filing omitted confidential holdings, a later amendment may add them. Timeline DIS DISNEY WALT CO More: the full row for DISNEY WALT CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,829,568 shares; 2024Q4: 4,428,068 shares; 2025Q1: 5,496,223 shares; 2025Q2: 4,874,268 shares; 2025Q3: 5,198,968 shares; 2025Q4: 4,125,991 shares; 2026Q1: 2,401,591 shares 2,401,591 $231M 1.37% -1,724,400 The filing omitted confidential holdings, a later amendment may add them. Timeline MA MASTERCARD INCORPORATED More: the full row for MASTERCARD INCORPORATED Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 506,671 shares; 2024Q4: 295,671 shares; 2025Q1: 201,371 shares; 2025Q2: 152,071 shares; 2025Q3: 213,771 shares; 2025Q4: 172,671 shares; 2026Q1: 435,071 shares 435,071 $217M 1.29% +262,400 The filing omitted confidential holdings, a later amendment may add them. Timeline MCK MCKESSON CORP More: the full row for MCKESSON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 610,700 shares; 2025Q1: 552,500 shares; 2025Q2: 314,600 shares; 2025Q3: 327,100 shares; 2025Q4: 298,900 shares; 2026Q1: 234,300 shares 234,300 $203M 1.2% -64,600 The filing omitted confidential holdings, a later amendment may add them. Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,660,866 shares; 2024Q4: 5,674,466 shares; 2025Q1: 5,700,466 shares; 2025Q2: 5,767,466 shares; 2025Q3: 5,781,066 shares; 2025Q4: 5,159,505 shares; 2026Q1: 5,684,000 shares 5,684,000 $192M 1.14% +524,495 The filing omitted confidential holdings, a later amendment may add them. Timeline CNTA CENTESSA PHARMACEUTICALS PLC More: the full row for CENTESSA PHARMACEUTICALS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,814,318 shares; 2024Q4: 3,498,709 shares; 2025Q1: 4,334,318 shares; 2025Q2: 4,529,318 shares; 2025Q3: 4,331,318 shares; 2025Q4: 5,377,068 shares; 2026Q1: 4,809,000 shares 4,809,000 $191M 1.13% -568,068 The filing omitted confidential holdings, a later amendment may add them. Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 4,000,000 shares; 2025Q1: 4,610,930 shares; 2025Q2: 9,157,000 shares; 2025Q3: 10,757,000 shares; 2025Q4: 13,061,411 shares; 2026Q1: 9,097,411 shares 9,097,411 $190M 1.13% -3,964,000 The filing omitted confidential holdings, a later amendment may add them. Timeline GRAL GRAIL INC More: the full row for GRAIL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 502,000 shares; 2025Q3: 1,349,000 shares; 2025Q4: 2,342,684 shares; 2026Q1: 3,253,684 shares 3,253,684 $168M 1% +911,000 The filing omitted confidential holdings, a later amendment may add them. Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,000,981 shares; 2025Q1: 1,143,818 shares; 2025Q2: 1,143,818 shares; 2025Q3: 1,143,818 shares; 2025Q4: 2,066,818 shares; 2026Q1: 3,580,818 shares 3,580,818 $137M 0.81% +1,514,000 The filing omitted confidential holdings, a later amendment may add them. Timeline THC TENET HEALTHCARE CORP More: the full row for TENET HEALTHCARE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 692,442 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 529,000 shares; 2025Q3: 414,000 shares; 2025Q4: 372,153 shares; 2026Q1: 452,153 shares 452,153 $85.3M 0.51% +80,000 The filing omitted confidential holdings, a later amendment may add them. Timeline CAH CARDINAL HEALTH INC More: the full row for CARDINAL HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 273,000 shares; 2025Q2: 454,000 shares; 2025Q3: 253,000 shares; 2025Q4: 576,000 shares; 2026Q1: 368,000 shares 368,000 $77.8M 0.46% -208,000 The filing omitted confidential holdings, a later amendment may add them. Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000 shares; 2026Q1: 1,261,000 shares 1,261,000 $73.3M 0.43% +1,256,000 The filing omitted confidential holdings, a later amendment may add them. Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 836,000 shares 836,000 $70.2M 0.42% new The filing omitted confidential holdings, a later amendment may add them. Timeline BTSG BRIGHTSPRING HEALTH SVCS INC More: the full row for BRIGHTSPRING HEALTH SVCS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 22,000 shares; 2024Q4: 22,000 shares; 2025Q1: 22,000 shares; 2025Q2: 22,000 shares; 2025Q3: 22,000 shares; 2025Q4: 22,000 shares; 2026Q1: 1,617,000 shares 1,617,000 $68.9M 0.41% +1,595,000 The filing omitted confidential holdings, a later amendment may add them. Timeline TWST TWIST BIOSCIENCE CORP More: the full row for TWIST BIOSCIENCE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 340,650 shares; 2024Q4: 7,650 shares; 2025Q1: 7,650 shares; 2025Q2: 7,650 shares; 2025Q3: 7,650 shares; 2025Q4: 7,650 shares; 2026Q1: 1,427,650 shares 1,427,650 $67.8M 0.4% +1,420,000 The filing omitted confidential holdings, a later amendment may add them. Timeline BIDU BAIDU INC More: the full row for BAIDU INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 207,996 shares; 2025Q4: 315,300 shares; 2026Q1: 443,785 shares 443,785 $49.4M 0.29% +128,485 The filing omitted confidential holdings, a later amendment may add them. Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 8,000 shares; 2025Q3: 8,000 shares; 2025Q4: 8,000 shares; 2026Q1: 674,000 shares 674,000 $45.6M 0.27% +666,000 The filing omitted confidential holdings, a later amendment may add them. Timeline AZN ASTRAZENECA PLC More: the full row for ASTRAZENECA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 226,499 shares 226,499 $44.7M 0.26% new The filing omitted confidential holdings, a later amendment may add them. Timeline MRK MERCK & CO INC More: the full row for MERCK & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 361,000 shares 361,000 $43.4M 0.26% new The filing omitted confidential holdings, a later amendment may add them. Timeline ACHC ACADIA HEALTHCARE COMPANY IN More: the full row for ACADIA HEALTHCARE COMPANY IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,736,800 shares 1,736,800 $40.6M 0.24% new The filing omitted confidential holdings, a later amendment may add them. Timeline WELL WELLTOWER INC More: the full row for WELLTOWER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 343,000 shares; 2026Q1: 200,000 shares 200,000 $39.5M 0.23% -143,000 The filing omitted confidential holdings, a later amendment may add them. Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 12,000 shares; 2024Q4: 12,000 shares; 2025Q1: 12,000 shares; 2025Q2: 12,000 shares; 2025Q3: 12,000 shares; 2025Q4: 12,000 shares; 2026Q1: 1,546,000 shares 1,546,000 $38.4M 0.23% +1,534,000 The filing omitted confidential holdings, a later amendment may add them. Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,108,262 shares; 2024Q4: 2,108,262 shares; 2025Q1: 2,122,262 shares; 2025Q2: 2,122,262 shares; 2025Q3: 2,122,262 shares; 2025Q4: 2,772,262 shares; 2026Q1: 2,871,862 shares 2,871,862 $36.3M 0.22% +99,600 The filing omitted confidential holdings, a later amendment may add them. Timeline JNJ JOHNSON & JOHNSON More: the full row for JOHNSON & JOHNSON Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 148,000 shares 148,000 $36.2M 0.21% new The filing omitted confidential holdings, a later amendment may add them. Timeline BBNX BETA BIONICS INC More: the full row for BETA BIONICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,332,220 shares; 2025Q2: 4,203,920 shares; 2025Q3: 4,313,920 shares; 2025Q4: 4,313,920 shares; 2026Q1: 3,607,920 shares 3,607,920 $36.2M 0.21% -706,000 The filing omitted confidential holdings, a later amendment may add them. Timeline ASMB ASSEMBLY BIOSCIENCES INC More: the full row for ASSEMBLY BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,227,590 shares; 2025Q4: 1,227,590 shares; 2026Q1: 1,227,590 shares 1,227,590 $34.1M 0.2% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline JOYY JOYY INC More: the full row for JOYY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 780,000 shares; 2025Q2: 787,906 shares; 2025Q3: 625,000 shares; 2025Q4: 578,200 shares; 2026Q1: 578,200 shares 578,200 $33.8M 0.2% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NTES NETEASE COM INC More: the full row for NETEASE COM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 291,219 shares 291,219 $32.6M 0.19% new The filing omitted confidential holdings, a later amendment may add them. Timeline NVO NOVO-NORDISK A S More: the full row for NOVO-NORDISK A S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 782,000 shares 782,000 $28.7M 0.17% new The filing omitted confidential holdings, a later amendment may add them. Timeline BITW BITWISE 10 CRYPTO INDEX ETF More: the full row for BITWISE 10 CRYPTO INDEX ETF Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,385,500 shares; 2026Q1: 603,000 shares 603,000 $26.9M 0.16% -2,782,500 The filing omitted confidential holdings, a later amendment may add them. Timeline FRNM PERCEPTIVE CAP SOLUTIONS COR More: the full row for PERCEPTIVE CAP SOLUTIONS COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,250,000 shares; 2026Q1: 2,250,000 shares 2,250,000 $24.7M 0.15% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline RPRX ROYALTY PHARMA PLC More: the full row for ROYALTY PHARMA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 493,000 shares 493,000 $23.6M 0.14% new The filing omitted confidential holdings, a later amendment may add them. Timeline NERV MINERVA NEUROSCIENCES INC More: the full row for MINERVA NEUROSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,365,000 shares; 2026Q1: 2,365,000 shares 2,365,000 $14.2M 0.08% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CECO CECO ENVIRONMENTAL CORP More: the full row for CECO ENVIRONMENTAL CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 234,000 shares 234,000 $13.9M 0.08% new The filing omitted confidential holdings, a later amendment may add them. Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 916,000 shares 916,000 $13.7M 0.08% new The filing omitted confidential holdings, a later amendment may add them. Timeline GDS GDS HLDGS LTD More: the full row for GDS HLDGS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,531,133 shares; 2024Q4: 1,531,133 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 292,000 shares 292,000 $11.8M 0.07% new The filing omitted confidential holdings, a later amendment may add them. Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 373,000 shares 373,000 $11.1M 0.07% new The filing omitted confidential holdings, a later amendment may add them. Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,997,000 shares; 2025Q4: 40,000 shares; 2026Q1: 354,000 shares 354,000 $10.7M 0.06% +314,000 The filing omitted confidential holdings, a later amendment may add them. Timeline FORM FORMFACTOR INC More: the full row for FORMFACTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 56,500 shares 56,500 $5.48M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline MTZ MASTEC INC More: the full row for MASTEC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,000 shares 17,000 $5.47M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline ENTG ENTEGRIS INC More: the full row for ENTEGRIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 45,500 shares 45,500 $5.33M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline C CITIGROUP INC More: the full row for CITIGROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 47,000 shares 47,000 $5.33M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline VNET VNET GROUP INC More: the full row for VNET GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 650,000 shares; 2024Q4: 650,000 shares; 2025Q1: 2,439,120 shares; 2025Q2: 2,994,120 shares; 2025Q3: 5,489,120 shares; 2025Q4: 6,285,386 shares; 2026Q1: 623,347 shares 623,347 $5.23M 0.03% -5,662,039 The filing omitted confidential holdings, a later amendment may add them. Timeline H HYATT HOTELS CORP More: the full row for HYATT HOTELS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 36,000 shares 36,000 $5.18M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline WAL WESTERN ALLIANCE BANCORP More: the full row for WESTERN ALLIANCE BANCORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 73,000 shares 73,000 $5.17M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline TKR TIMKEN CO More: the full row for TIMKEN CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 51,000 shares 51,000 $5.13M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline FLEX FLEX LTD More: the full row for FLEX LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 78,000 shares 78,000 $5.11M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline SPGI S&P GLOBAL INC More: the full row for S&P GLOBAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 475,334 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,000 shares 12,000 $5.1M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline LFUS LITTELFUSE INC More: the full row for LITTELFUSE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 15,000 shares 15,000 $5.09M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline PIPR PIPER SANDLER COMPANIES More: the full row for PIPER SANDLER COMPANIES Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 66,000 shares 66,000 $5.05M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline AIR AAR CORP More: the full row for AAR CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 46,000 shares 46,000 $5.04M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline RIO RIO TINTO PLC More: the full row for RIO TINTO PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,800 shares 53,800 $5.02M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline GTX GARRETT MOTION INC More: the full row for GARRETT MOTION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 275,000 shares 275,000 $5M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline ROL ROLLINS INC More: the full row for ROLLINS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 93,000 shares 93,000 $4.97M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline AFRM AFFIRM HLDGS INC More: the full row for AFFIRM HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 108,000 shares 108,000 $4.95M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline INTR INTER & CO INC More: the full row for INTER & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 614,500 shares 614,500 $4.89M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline CMI CUMMINS INC More: the full row for CUMMINS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,000 shares 9,000 $4.84M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline FISV FISERV INC More: the full row for FISERV INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 86,000 shares 86,000 $4.8M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline VRT VERTIV HOLDINGS CO More: the full row for VERTIV HOLDINGS CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 19,000 shares 19,000 $4.76M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline AMKR AMKOR TECHNOLOGY INC More: the full row for AMKOR TECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 464,000 shares; 2026Q1: 104,000 shares 104,000 $4.68M 0.03% -360,000 The filing omitted confidential holdings, a later amendment may add them. Timeline RNA ATRIUM THERAPEUTICS INC More: the full row for ATRIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 349,360 shares 349,360 $4.67M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline GFS GLOBALFOUNDRIES INC More: the full row for GLOBALFOUNDRIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 105,000 shares 105,000 $4.67M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline MOH MOLINA HEALTHCARE INC More: the full row for MOLINA HEALTHCARE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares 35,000 $4.67M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares 1,000,000 $4.55M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline TENB TENABLE HLDGS INC More: the full row for TENABLE HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 265,000 shares 265,000 $4.48M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline PRME PRIME MEDICINE INC More: the full row for PRIME MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 750,000 shares; 2025Q3: 4,750,000 shares; 2025Q4: 1,240,843 shares; 2026Q1: 1,240,843 shares 1,240,843 $4.32M 0.03% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NOW SERVICENOW INC More: the full row for SERVICENOW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 295,050 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 41,000 shares 41,000 $4.29M 0.03% new The filing omitted confidential holdings, a later amendment may add them. Timeline SMC SUMMIT MIDSTREAM CORPORATION More: the full row for SUMMIT MIDSTREAM CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 58,214 shares; 2024Q4: 58,214 shares; 2025Q1: 58,214 shares; 2025Q2: 58,214 shares; 2025Q3: 58,214 shares; 2025Q4: 58,214 shares; 2026Q1: 58,214 shares 58,214 $1.76M 0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,319 shares; 2024Q4: 3,319 shares; 2025Q1: 3,319 shares; 2025Q2: 3,319 shares; 2025Q3: 3,319 shares; 2025Q4: 3,319 shares; 2026Q1: 3,319 shares 3,319 $1.74M 0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,250,400 shares; 2025Q1: 2,250,400 shares; 2025Q2: 41,000 shares; 2025Q3: 41,000 shares; 2025Q4: 41,000 shares; 2026Q1: 41,000 shares 41,000 $1.25M 0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 628,800 shares; 2025Q1: 15,800 shares; 2025Q2: 15,800 shares; 2025Q3: 15,800 shares; 2025Q4: 15,800 shares; 2026Q1: 15,800 shares 15,800 $991K 0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ANNAW ALEANNA INC More: the full row for ALEANNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 990,000 shares; 2025Q1: 990,000 shares; 2025Q2: 990,000 shares; 2025Q3: 990,000 shares; 2025Q4: 990,000 shares; 2026Q1: 990,000 shares 990,000 $802K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 8,000 shares; 2025Q3: 8,000 shares; 2025Q4: 109,000 shares; 2026Q1: 8,000 shares 8,000 $739K <0.01% -101,000 The filing omitted confidential holdings, a later amendment may add them. Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,389,800 shares; 2025Q2: 691,663 shares; 2025Q3: 20,800 shares; 2025Q4: 20,800 shares; 2026Q1: 20,800 shares 20,800 $735K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ALVO ALVOTECH More: the full row for ALVOTECH Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 199,675 shares; 2024Q4: 199,675 shares; 2025Q1: 199,675 shares; 2025Q2: 199,675 shares; 2025Q3: 199,675 shares; 2025Q4: 199,675 shares; 2026Q1: 199,675 shares 199,675 $685K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,000 shares; 2024Q4: 4,000 shares; 2025Q1: 4,000 shares; 2025Q2: 4,000 shares; 2025Q3: 4,000 shares; 2025Q4: 4,000 shares; 2026Q1: 4,000 shares 4,000 $676K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 17,000 shares; 2024Q4: 17,000 shares; 2025Q1: 17,000 shares; 2025Q2: 17,000 shares; 2025Q3: 17,000 shares; 2025Q4: 17,000 shares; 2026Q1: 17,000 shares 17,000 $654K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ANNA ALEANNA INC More: the full row for ALEANNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 78,400 shares; 2025Q1: 78,400 shares; 2025Q2: 78,400 shares; 2025Q3: 78,400 shares; 2025Q4: 78,400 shares; 2026Q1: 78,400 shares 78,400 $650K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ARQT ARCUTIS BIOTHERAPEUTICS INC More: the full row for ARCUTIS BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 26,000 shares; 2024Q4: 26,000 shares; 2025Q1: 26,000 shares; 2025Q2: 26,000 shares; 2025Q3: 26,000 shares; 2025Q4: 26,000 shares; 2026Q1: 26,000 shares 26,000 $613K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000 shares; 2026Q1: 4,000 shares 4,000 $457K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline LIVN LIVANOVA PLC More: the full row for LIVANOVA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 37,000 shares; 2025Q2: 6,000 shares; 2025Q3: 6,000 shares; 2025Q4: 6,000 shares; 2026Q1: 6,000 shares 6,000 $381K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline TERN TERNS PHARMACEUTICALS INC More: the full row for TERNS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 642,000 shares; 2026Q1: 7,000 shares 7,000 $369K <0.01% -635,000 The filing omitted confidential holdings, a later amendment may add them. Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,800 shares; 2025Q4: 4,800 shares; 2026Q1: 4,800 shares 4,800 $360K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares; 2025Q3: 12,000 shares; 2025Q4: 12,000 shares; 2026Q1: 12,000 shares 12,000 $357K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline GMED GLOBUS MED INC More: the full row for GLOBUS MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,600 shares; 2024Q4: 3,600 shares; 2025Q1: 83,000 shares; 2025Q2: 210,000 shares; 2025Q3: 4,000 shares; 2025Q4: 4,000 shares; 2026Q1: 4,000 shares 4,000 $345K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 7,000 shares; 2025Q1: 7,000 shares; 2025Q2: 7,000 shares; 2025Q3: 7,000 shares; 2025Q4: 7,000 shares; 2026Q1: 7,000 shares 7,000 $344K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ONC BEONE MEDICINES LTD More: the full row for BEONE MEDICINES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,100 shares; 2024Q4: 1,100 shares; 2025Q1: 1,100 shares; 2025Q2: 1,100 shares; 2025Q3: 1,100 shares; 2025Q4: 1,100 shares; 2026Q1: 1,100 shares 1,100 $327K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline WGS GENEDX HOLDINGS CORP More: the full row for GENEDX HOLDINGS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 195,000 shares; 2025Q1: 303,000 shares; 2025Q2: 326,677 shares; 2025Q3: 5,000 shares; 2025Q4: 70,000 shares; 2026Q1: 5,000 shares 5,000 $321K <0.01% -65,000 The filing omitted confidential holdings, a later amendment may add them. Timeline COR CENCORA INC More: the full row for CENCORA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 235,200 shares; 2024Q4: 1,000 shares; 2025Q1: 1,000 shares; 2025Q2: 1,000 shares; 2025Q3: 1,000 shares; 2025Q4: 1,000 shares; 2026Q1: 1,000 shares 1,000 $314K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NUVL NUVALENT INC More: the full row for NUVALENT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 150,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 3,000 shares 3,000 $307K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline PGNY PROGYNY INC More: the full row for PROGYNY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 931,307 shares; 2024Q4: 18,000 shares; 2025Q1: 18,000 shares; 2025Q2: 18,000 shares; 2025Q3: 18,000 shares; 2025Q4: 18,000 shares; 2026Q1: 18,000 shares 18,000 $306K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,000 shares; 2026Q1: 9,000 shares 9,000 $293K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 18,000 shares 18,000 $291K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline EHC ENCOMPASS HEALTH CORP More: the full row for ENCOMPASS HEALTH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,000 shares; 2024Q4: 461,000 shares; 2025Q1: 619,000 shares; 2025Q2: 708,000 shares; 2025Q3: 571,000 shares; 2025Q4: 234,500 shares; 2026Q1: 3,000 shares 3,000 $290K <0.01% -231,500 The filing omitted confidential holdings, a later amendment may add them. Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 791,000 shares; 2025Q4: not reported; 2026Q1: 4,000 shares 4,000 $288K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline GKOS GLAUKOS CORP More: the full row for GLAUKOS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,600 shares; 2024Q4: 2,600 shares; 2025Q1: 2,600 shares; 2025Q2: 2,600 shares; 2025Q3: 2,600 shares; 2025Q4: 2,600 shares; 2026Q1: 2,600 shares 2,600 $280K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 3,000 shares 3,000 $277K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SBRA SABRA HEALTH CARE REIT INC More: the full row for SABRA HEALTH CARE REIT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 14,000 shares; 2024Q4: 14,000 shares; 2025Q1: 14,000 shares; 2025Q2: 14,000 shares; 2025Q3: 14,000 shares; 2025Q4: 14,000 shares; 2026Q1: 14,000 shares 14,000 $269K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: 2,000 shares; 2025Q1: 2,000 shares; 2025Q2: 2,000 shares; 2025Q3: 2,000 shares; 2025Q4: 2,000 shares; 2026Q1: 1,000 shares 1,000 $258K <0.01% -1,000 The filing omitted confidential holdings, a later amendment may add them. Timeline OMER OMEROS CORP More: the full row for OMEROS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 23,000 shares; 2026Q1: 23,000 shares 23,000 $243K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,000 shares 11,000 $242K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline APLS APELLIS PHARMACEUTICALS INC More: the full row for APELLIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,000 shares 6,000 $241K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline HQY HEALTHEQUITY INC More: the full row for HEALTHEQUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,800 shares; 2024Q4: 2,800 shares; 2025Q1: 421,800 shares; 2025Q2: 319,800 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares; 2026Q1: 2,800 shares 2,800 $234K <0.01% -2,200 The filing omitted confidential holdings, a later amendment may add them. Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $234K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline FOLD AMICUS THERAPEUTIC More: the full row for AMICUS THERAPEUTIC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 16,000 shares; 2024Q4: 16,000 shares; 2025Q1: 16,000 shares; 2025Q2: 16,000 shares; 2025Q3: 16,000 shares; 2025Q4: 16,000 shares; 2026Q1: 16,000 shares 16,000 $231K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 14,000 shares; 2025Q2: 14,000 shares; 2025Q3: 565,000 shares; 2025Q4: 14,000 shares; 2026Q1: 14,000 shares 14,000 $229K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,000 shares; 2025Q4: 24,000 shares; 2026Q1: 24,000 shares 24,000 $228K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline VCYT VERACYTE INC More: the full row for VERACYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 7,000 shares; 2026Q1: 7,000 shares 7,000 $225K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline GRFS GRIFOLS S A More: the full row for GRIFOLS S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: 28,000 shares; 2025Q1: 28,000 shares; 2025Q2: 28,000 shares; 2025Q3: 28,000 shares; 2025Q4: 28,000 shares; 2026Q1: 28,000 shares 28,000 $225K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 805,000 shares; 2025Q4: 387,000 shares; 2026Q1: 2,000 shares 2,000 $223K <0.01% -385,000 The filing omitted confidential holdings, a later amendment may add them. Timeline GEHC GE HEALTHCARE TECHNOLOGIES I More: the full row for GE HEALTHCARE TECHNOLOGIES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 124,000 shares; 2025Q1: 537,000 shares; 2025Q2: 1,322,000 shares; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 3,000 shares 3,000 $214K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline RVMDW REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 120,085 shares; 2024Q4: 120,085 shares; 2025Q1: 120,085 shares; 2025Q2: 120,085 shares; 2025Q3: 120,085 shares; 2025Q4: 120,085 shares; 2026Q1: 120,085 shares 120,085 $209K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline HIMS HIMS & HERS HEALTH INC More: the full row for HIMS & HERS HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,000 shares; 2024Q4: 8,377,000 shares; 2025Q1: 7,953,705 shares; 2025Q2: 8,213,581 shares; 2025Q3: 10,746,852 shares; 2025Q4: 3,386,986 shares; 2026Q1: 10,000 shares 10,000 $208K <0.01% -3,376,986 The filing omitted confidential holdings, a later amendment may add them. Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,300 shares 1,300 $207K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline MMSI MERIT MED SYS INC More: the full row for MERIT MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,000 shares; 2024Q4: 3,000 shares; 2025Q1: 3,000 shares; 2025Q2: 3,000 shares; 2025Q3: 3,000 shares; 2025Q4: 3,000 shares; 2026Q1: 3,000 shares 3,000 $207K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SUPN SUPERNUS PHARMACEUTICALS More: the full row for SUPERNUS PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,000 shares 4,000 $207K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline HR HEALTHCARE RLTY TR More: the full row for HEALTHCARE RLTY TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,603,000 shares; 2024Q4: 3,264,000 shares; 2025Q1: 12,000 shares; 2025Q2: 12,000 shares; 2025Q3: 12,000 shares; 2025Q4: 12,000 shares; 2026Q1: 12,000 shares 12,000 $204K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 11,000 shares; 2025Q4: 11,000 shares; 2026Q1: 11,000 shares 11,000 $198K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,000 shares 22,000 $197K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline PGEN PRECIGEN INC More: the full row for PRECIGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares 50,000 $194K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SDGR SCHRODINGER INC More: the full row for SCHRODINGER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,106,000 shares; 2025Q3: 284,000 shares; 2025Q4: 71,000 shares; 2026Q1: 17,000 shares 17,000 $193K <0.01% -54,000 The filing omitted confidential holdings, a later amendment may add them. Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 428,000 shares; 2024Q4: 229,121 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $181K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NVAX NOVAVAX INC More: the full row for NOVAVAX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 16,000 shares; 2024Q4: 16,000 shares; 2025Q1: 16,000 shares; 2025Q2: 16,000 shares; 2025Q3: 780,000 shares; 2025Q4: 195,000 shares; 2026Q1: 22,000 shares 22,000 $179K <0.01% -173,000 The filing omitted confidential holdings, a later amendment may add them. Timeline PACB PACIFIC BIOSCIENCES CALIF IN More: the full row for PACIFIC BIOSCIENCES CALIF IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 135,000 shares; 2024Q4: 135,000 shares; 2025Q1: 135,000 shares; 2025Q2: 135,000 shares; 2025Q3: 135,000 shares; 2025Q4: 135,000 shares; 2026Q1: 135,000 shares 135,000 $178K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SLS SELLAS LIFE SCIENCES GROUP I More: the full row for SELLAS LIFE SCIENCES GROUP I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares 40,000 $169K <0.01% new The filing omitted confidential holdings, a later amendment may add them. Timeline ADPT ADAPTIVE BIOTECHNOLOGIES COR More: the full row for ADAPTIVE BIOTECHNOLOGIES COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,000 shares; 2026Q1: 11,000 shares 11,000 $153K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 18,000 shares; 2026Q1: 18,000 shares 18,000 $152K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NEO NEOGENOMICS INC More: the full row for NEOGENOMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,000 shares; 2026Q1: 19,000 shares 19,000 $141K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,000 shares; 2024Q4: 23,000 shares; 2025Q1: 23,000 shares; 2025Q2: 23,000 shares; 2025Q3: 23,000 shares; 2025Q4: 23,000 shares; 2026Q1: 23,000 shares 23,000 $138K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline OSCR OSCAR HEALTH INC More: the full row for OSCAR HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,000 shares; 2024Q4: 11,000 shares; 2025Q1: 11,000 shares; 2025Q2: 1,476,000 shares; 2025Q3: 3,639,000 shares; 2025Q4: 264,000 shares; 2026Q1: 11,000 shares 11,000 $126K <0.01% -253,000 The filing omitted confidential holdings, a later amendment may add them. Timeline NUVB NUVATION BIO INC More: the full row for NUVATION BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 29,000 shares; 2026Q1: 29,000 shares 29,000 $124K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 26,000 shares; 2024Q4: 26,000 shares; 2025Q1: 26,000 shares; 2025Q2: 26,000 shares; 2025Q3: 26,000 shares; 2025Q4: 26,000 shares; 2026Q1: 26,000 shares 26,000 $91.3K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline SLDPW SOLID POWER INC More: the full row for SOLID POWER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 405,316 shares; 2024Q4: 405,316 shares; 2025Q1: 405,316 shares; 2025Q2: 405,316 shares; 2025Q3: 405,316 shares; 2025Q4: 405,316 shares; 2026Q1: 405,316 shares 405,316 $88.4K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 27,600 shares; 2024Q4: 27,600 shares; 2025Q1: 27,600 shares; 2025Q2: 27,600 shares; 2025Q3: 27,600 shares; 2025Q4: 27,600 shares; 2026Q1: 27,600 shares 27,600 $85K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: 28,000 shares; 2025Q1: 28,000 shares; 2025Q2: 28,000 shares; 2025Q3: 28,000 shares; 2025Q4: 28,000 shares; 2026Q1: 28,000 shares 28,000 $73.6K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline TVRD TVARDI THERAPEUTICS INC More: the full row for TVARDI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 43,225 shares; 2025Q3: 43,225 shares; 2025Q4: 43,225 shares; 2026Q1: 21,438 shares 21,438 $68.2K <0.01% -21,787 The filing omitted confidential holdings, a later amendment may add them. Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 43,000 shares; 2024Q4: 43,000 shares; 2025Q1: 43,000 shares; 2025Q2: 43,000 shares; 2025Q3: 43,000 shares; 2025Q4: 43,000 shares; 2026Q1: 43,000 shares 43,000 $64.1K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline BGLWW BLUE GOLD LTD More: the full row for BLUE GOLD LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 300,000 shares 300,000 $60K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline RANI RANI THERAPEUTICS HLDGS INC More: the full row for RANI THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 78,000 shares; 2026Q1: 78,000 shares 78,000 $57.3K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline IRWD IRONWOOD PHARMACEUTICALS INC More: the full row for IRONWOOD PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,000 shares; 2024Q4: 13,000 shares; 2025Q1: 13,000 shares; 2025Q2: 13,000 shares; 2025Q3: 13,000 shares; 2025Q4: 13,000 shares; 2026Q1: 13,000 shares 13,000 $45.6K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline EVH EVOLENT HEALTH INC More: the full row for EVOLENT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 639,000 shares; 2024Q4: 14,000 shares; 2025Q1: 14,000 shares; 2025Q2: 14,000 shares; 2025Q3: 14,000 shares; 2025Q4: 14,000 shares; 2026Q1: 14,000 shares 14,000 $31.9K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline CGC CANOPY GROWTH CORPORATION More: the full row for CANOPY GROWTH CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: 30,000 shares; 2025Q1: 30,000 shares; 2025Q2: 30,000 shares; 2025Q3: 30,000 shares; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares 30,000 $28.5K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline NVNIW NVNI GROUP LIMITED More: the full row for NVNI GROUP LIMITED Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 375,000 shares; 2024Q4: 375,000 shares; 2025Q1: 375,000 shares; 2025Q2: 375,000 shares; 2025Q3: 375,000 shares; 2025Q4: 375,000 shares; 2026Q1: 375,000 shares 375,000 $17.8K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline BYND BEYOND MEAT INC More: the full row for BEYOND MEAT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 19,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 19,000 shares; 2025Q3: 19,000 shares; 2025Q4: 19,000 shares; 2026Q1: 19,000 shares 19,000 $13.3K <0.01% 0 The filing omitted confidential holdings, a later amendment may add them. Timeline